Navigation
banner

Diabetes Summit

2018-04-212018-02-272018-01-19
Register 3 for the price of 2 with the coupon code rcdvb!


Dear Colleague,

GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 9-11, 2018 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions, highlight basic research, novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.

Focus Groups Discussions:

  1. Part I (Challenges and Opportunities)
  2. Part II (Solutions & Action Items)

Drug Discovery & Development for Diabetes:

  1. Opening Keynote Session – Historical Perspective & State of the Science & Industry 
  2. Type I Diabetes – Preclinical & Clinical Development
  3. Type II Diabetes – Preclinical & Clinical Development
  4. Devices & Digital Aids in Diabetes Management

Funding, Partnering & Commercialization of Diabetes Technologies:

  1. Industry Partnering with Academia & CROs to Advance Diabetes Research
  2. Funding & Commercialization of Diabetes Technologies
  3. Award Ceremony & Closing Keynote Session – Predictions for the Future
  4. Keynote Panel Discussion

 

We look forward to seeing you at the conference!

Best regards,

The 2018 Advisory Committee

2018 Advisory Board Members
Robert Geho, Diasome Pharmaceuticals Inc
Zan Fleming, Kinexum
Alan Cherrington, Vanderbilt
Brian T. Bloomquist, Eli Lilly
Aaron Schwartz, Novo Nordisk
Riccardo Perfetti, Sanofi Diabetes & Cardiovascular Business Unit
Nandan Padukone, Joslin Diabetes Center
Thomas Seoh, Kinexum
Jonathan Behr, JDRF
Nathaniel Heintzman, Dexcom
Vivek Shenoy, Renovo Neural
Judith Gorski, Crown Bioscience
Vijay Koya, Boston Scientific

 

Schedule for Sessions

4:00

Registration Opens

5:00

Opening Remarks by GTCbio

5:10

Program Preview by Alan Cherrington

5:30

Focus Group Discussions – Part I (Challenges and Opportunities)

5:30-Jane Chiang - Focus Group: Assessing Role of HbA1c in Diabetes Drug Development

5:30-Felicia Pagliuca - Focus Group: Manufacturing & Regulatory Landscape for Cell Therapy in Diabetes

6:30

Day 1 Concludes

7:30

Hot Breakfast & Registration

8:30

Opening Keynote Session – Historical Perspective and State of the Science & Industry

8:30-Andrew Young - The Emergence and Ascent of Regulatory Peptides in the Treatment of Metabolic Diseases: A Personal Perspective

9:10-Domenico Accili - New Treatments and New Targets for Diabetes

9:50

Morning Networking Break

10:30

Type I Diabetes – Preclinical and Clinical Development

10:30-Julia Greenstein - JDRF Strategy to Restore Immune Balance in Type 1 Diabetes

10:55-Michael Brehm - Humanized Mouse Models for Type 1 Diabetes Pathogenesis and Therapy

11:20-Denise Faustman - Updates on Global Trials Using the BCG Vaccine: T1D and Other Autoimmune Diseases

11:45-Felicia Pagliuca - Development of a Stem Cell Derived Pancreatic Islet Cell Therapy for Diabetes

12:10-Alain Stricker-Krongrad - Therapeutic Efficacy of Antidiabetic Drugs in the Diabetic Miniature Swine: A Rationale For Comparative Clinical Trials Modeling in a Translational Animal Model

12:25

Lunch Workshop

12:45

Lunch Workshop Presentation

12:45-Judith Gorski - Implications of Continuous Glucose Monitoring in Diabetes Research and Patient Management

1:50

Type II Diabetes – Preclinical and Clinical Development

1:50-William Bachovchin - Untapped Potential of the DASH Family of Post Proline Cleaving Enzymes as Targets for Diabetes

2:15-Michael Zemel - Clinical Utility of Energy-Sensing Targets for Diabetes & Metabolic Syndrome

2:40-David Maggs - The Role of Device-based Intervention in Metabolic Disease: The How, What and Why

3:05-Maria Trujillo - Translational PKPD: Empowering Early Drug Development

3:30-Donald Scott - Lessons From Studying Glucose-responsive Transcription Factors in Beta Cells

3:55

Afternoon Networking Break

4:25

Devices and Digital Aids in Diabetes Management

4:25-Scott Johnson - mySugr - Stay Smart and Get Out of The Way

4:50-Carl Brandt - Why Digital Behaviour Change is so Powerful When Combined with Real Human Relationships

5:15-Steven Russell - Update on Automated Glucose Control with the Bionic Pancreas

5:40

Networking Reception & Poster Session

7:00

Hot Breakfast

7:15

Focus Group Discussions – Part II (Solutions & Action Items)

7:15-Jane Chiang - Focus Group: Assessing Role of HbA1c in Diabetes Drug Development

7:15-Felicia Pagliuca - Focus Group: Manufacturing & Regulatory Landscape for Cell Therapy in Diabetes

8:30

Industry Partnering with Academia & CROs to Advance Diabetes Research

8:30-Alan Cherrington - The Symbiotic Relationship between Industry, CROs and Academia

8:55-Aaron Schwartz - Partnering with Novo Nordisk

9:20

Panel: Industry Partnering with Academia & CROs to Advance Diabetes Research

9:20-Jane Chiang - Panelist:

9:20-Judith Gorski - Moderator:

9:20-Aaron Schwartz - Panelist:

9:20-Dennis Guberski, - Panelist:

10:10

Morning Networking Break

10:40

Funding & Commercialization of Diabetes Technologies

10:40-Joseph Cook, Jr. - Is it Time For a Patient Centered Approach to Treating Diabetes and Obesity

11:05

Panel: Funding & Commercialization of Diabetes Technologies

11:05-Thomas Seoh - Moderator:

11:05-Jonathan Behr - Panelist:

11:05-Joseph Cook, Jr. - Panelist:

11:05-Wende Hutton - Panelist:

11:05-Martin Lafontaine - Panelist:

11:05-Jason Hafler - Panelist:

12:00

Lunch Provided by GTCbio

1:30

Award Ceremony & Closing Keynote Session – Predictions for future

1:30-Nir Barzilai - Preventing Diabetes by ‘Taming’ Aging

2:10

Keynote Panel Discussion

2:10-Alexander (Zan) Fleming - Moderator:

2:10-Nir Barzilai - Panelist:

2:10-Brian Bloomquist - Panelist:

2:10-Andrew Young - Panelist:

2:10-Julia Greenstein - Panelist:

3:00

Summit Concludes

 

registration button

registration button

Subscribe for updates